Is it time for medicine-based evidence?

JAMA. 2012 Apr 18;307(15):1641-3. doi: 10.1001/jama.2012.482.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Air Ambulances / statistics & numerical data*
  • Ambulances / statistics & numerical data*
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Aortic Aneurysm, Abdominal / mortality*
  • Aortic Aneurysm, Abdominal / surgery*
  • Bevacizumab
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Emergency Medical Services / methods*
  • Endovascular Procedures / mortality*
  • Female
  • Humans
  • Kidney Neoplasms / mortality*
  • Kidney Neoplasms / surgery*
  • Lung Neoplasms / drug therapy*
  • Male
  • Medicare / statistics & numerical data*
  • Nephrectomy / methods*
  • Nephrectomy / mortality*
  • Prostatic Neoplasms / radiotherapy*
  • Radiation Injuries*
  • Radiotherapy, Intensity-Modulated / adverse effects*
  • Vascular Surgical Procedures / mortality*
  • Wounds and Injuries / mortality*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab